Assessment of prognostic factors in patients with primary ocular adnexal lymphoma when considering competing risk elements

医学 比例危险模型 单变量 内科学 肿瘤科 生存分析 单变量分析 多元分析 流行病学 多元统计 统计 数学
作者
Jing Zeng,Xian‐Fen Cao,Jian Chen,Zhiping Liu,Jun Lyu,Qing Zhou
出处
期刊:Clinical and Experimental Ophthalmology [Wiley]
标识
DOI:10.1111/ceo.14427
摘要

Abstract Background Accurate prognostic factors for primary ocular adnexal lymphoma (POAL) are scarce. Survival models and prognostic factors derived without considering competing risk factors suffer from major statistical errors. This study aimed to accurately assess prognostic factors in POAL patients using competing risk models, and compare this to the traditional COX proportional hazards model. Methods This retrospective study utilised data from the Surveillance, Epidemiology, and End Results (SEER) program 2010–2015 and included patients with B‐cell POAL. The cumulative incidence function and Gray's test for cause‐specific survival were calculated as univariate analysis. The competing risk models were a Fine‐Gray subdistribution hazard model and a cause‐specific model, and a traditional COX model was employed as a multivariate analysis. Results This study enrolled 846 eligible patients with POAL: 60 patients (7.09%) died from POAL and 123 patients (14.54%) died from other causes. Multivariate competing risk models indicated that age, laterality, histology subtype, the 7th edition of American Joint Committee on Cancer stage T, and radiotherapy were independent predictors for cause‐specific survival of patients with POAL. There was high consistency between the two competing risk models. The COX model made several misestimations on the statistical significance and hazard ratios of prognostic factors. Conclusions This study established competing risk models as a method to assess POAL prognostic factors, which was more accurate than traditional methods that do not consider competing risk elements.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
liii完成签到,获得积分10
刚刚
Aug31完成签到 ,获得积分10
刚刚
背后的傥完成签到,获得积分10
1秒前
呼延含双完成签到,获得积分10
1秒前
贝壳z发布了新的文献求助10
2秒前
3秒前
mikaqyan完成签到,获得积分10
3秒前
3秒前
4秒前
华仔应助小轩爱晴采纳,获得10
4秒前
世界需要我发布了新的文献求助100
4秒前
汉堡包应助一点点采纳,获得10
4秒前
852应助云望采纳,获得10
5秒前
6秒前
6秒前
6秒前
冷艳的又蓝完成签到 ,获得积分10
7秒前
ww发布了新的文献求助10
8秒前
zsp完成签到,获得积分20
8秒前
顾北完成签到,获得积分10
9秒前
10秒前
科研通AI6.2应助hooke采纳,获得10
10秒前
标致醉波完成签到,获得积分10
10秒前
不嚼珍珠发布了新的文献求助10
11秒前
缥缈的飞荷完成签到 ,获得积分10
12秒前
魏林娟完成签到,获得积分10
12秒前
lcj发布了新的文献求助10
12秒前
12秒前
热心市民小红花应助fan5853采纳,获得10
13秒前
ys716完成签到,获得积分10
13秒前
13秒前
14秒前
15秒前
66发布了新的文献求助30
15秒前
15秒前
无聊的人雄完成签到,获得积分20
15秒前
15秒前
15秒前
呜呜呜发布了新的文献求助10
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6168730
求助须知:如何正确求助?哪些是违规求助? 7996426
关于积分的说明 16630766
捐赠科研通 5273979
什么是DOI,文献DOI怎么找? 2813579
邀请新用户注册赠送积分活动 1793314
关于科研通互助平台的介绍 1659250